| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786837 | European Journal of Surgical Oncology (EJSO) | 2018 | 7 Pages |
Abstract
High cytonuclear grade, mammographic microcalcification, young age and lack of endocrine therapy were risk factors for DCIS progression to invasive cancer. Surgical excision of high grade DCIS remains the treatment of choice. Given the uncertain long-term natural history of non-high grade DCIS, the option of active surveillance of women with this condition should be offered within a clinical trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anthony J. Maxwell, Karen Clements, Bridget Hilton, David J. Dodwell, Andrew Evans, Olive Kearins, Sarah E. Pinder, Jeremy Thomas, Matthew G. Wallis, Alastair M. Thompson,